These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 29221615)
1. Is exposure to aluminium adjuvants associated with social impairments in mice? A pilot study. Sheth SKS; Li Y; Shaw CA J Inorg Biochem; 2018 Apr; 181():96-103. PubMed ID: 29221615 [TBL] [Abstract][Full Text] [Related]
2. Administration of aluminium to neonatal mice in vaccine-relevant amounts is associated with adverse long term neurological outcomes. Shaw CA; Li Y; Tomljenovic L J Inorg Biochem; 2013 Nov; 128():237-44. PubMed ID: 23932735 [TBL] [Abstract][Full Text] [Related]
3. Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? Tomljenovic L; Shaw CA J Inorg Biochem; 2011 Nov; 105(11):1489-99. PubMed ID: 22099159 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the safety of aluminium adjuvant in the preparation of allergic rhinitis animal model]. Fan EZ; Xi L; Han DM; Zhang SZ; Li Y; Zhang L Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Aug; 44(8):664-8. PubMed ID: 19961775 [TBL] [Abstract][Full Text] [Related]
5. Reviewing the association between aluminum adjuvants in the vaccines and autism spectrum disorder. Boretti A J Trace Elem Med Biol; 2021 Jul; 66():126764. PubMed ID: 33930617 [TBL] [Abstract][Full Text] [Related]
6. Persistent subcutaneous nodules after immunotherapy injections for allergic asthma. Ozden MG; Kefeli M; Aydin F; Senturk N; Canturk T; Turanli AY J Cutan Pathol; 2009 Jul; 36(7):812-4. PubMed ID: 19519616 [TBL] [Abstract][Full Text] [Related]
7. Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration. Shaw CA; Petrik MS J Inorg Biochem; 2009 Nov; 103(11):1555-62. PubMed ID: 19740540 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of immunotherapy using various updosing schedules of a new SCIT product with an optimised allergen/aluminium hydroxide ratio. Jung K Allergy; 2011 Jul; 66 Suppl 95():41-3. PubMed ID: 21668852 [TBL] [Abstract][Full Text] [Related]
9. [Cutaneous ulcerating nodules after many years of immunotherapy]. Bouten H; Nijsten TE; Noordhoek Hegt V Ned Tijdschr Geneeskd; 2016; 160():A9554. PubMed ID: 26860748 [TBL] [Abstract][Full Text] [Related]
10. Aluminium hydroxide-induced granulomas in pigs. Valtulini S; Macchi C; Ballanti P; Cherel Y; Laval A; Theaker JM; Bak M; Ferretti E; Morvan H Vaccine; 2005 Jun; 23(30):3999-4004. PubMed ID: 15917121 [TBL] [Abstract][Full Text] [Related]
11. Role of aluminum adjuvant in producing an allergic rhinitis animal model. Xi L; Fan E; Zhao Y; Li Y; Zhang Y; Zhang L Genet Mol Res; 2014 Jul; 13(3):5173-81. PubMed ID: 25061742 [TBL] [Abstract][Full Text] [Related]
12. Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil. Inbar R; Weiss R; Tomljenovic L; Arango MT; Deri Y; Shaw CA; Chapman J; Blank M; Shoenfeld Y Immunol Res; 2017 Feb; 65(1):136-149. PubMed ID: 27421722 [TBL] [Abstract][Full Text] [Related]
13. Aluminium-adjuvanted vaccines--a review of the current state of knowledge. Gołoś A; Lutyńska A Przegl Epidemiol; 2015; 69(4):731-4, 871-4. PubMed ID: 27139352 [TBL] [Abstract][Full Text] [Related]
14. mTOR inhibitor reverses autistic-like social deficit behaviours in adult rats with both Tsc2 haploinsufficiency and developmental status epilepticus. Schneider M; de Vries PJ; Schönig K; Rößner V; Waltereit R Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):455-463. PubMed ID: 27263037 [TBL] [Abstract][Full Text] [Related]
15. Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine. Straw BE; MacLachlan NJ; Corbett WT; Carter PB; Schey HM Can J Comp Med; 1985 Apr; 49(2):149-51. PubMed ID: 4016580 [TBL] [Abstract][Full Text] [Related]
16. Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection. Bungener L; Geeraedts F; Ter Veer W; Medema J; Wilschut J; Huckriede A Vaccine; 2008 May; 26(19):2350-9. PubMed ID: 18400340 [TBL] [Abstract][Full Text] [Related]
17. Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease. Gherardi RK; Aouizerate J; Cadusseau J; Yara S; Authier FJ Morphologie; 2016 Jun; 100(329):85-94. PubMed ID: 26948677 [TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal administration of aluminium-based adjuvants produces severe transient systemic adverse events in mice. Freiberger SN; Leuthard DS; Duda A; Contassot E; Thallmair M; Kündig TM; Johansen P Eur J Pharm Sci; 2018 Mar; 115():362-368. PubMed ID: 29410031 [TBL] [Abstract][Full Text] [Related]
19. Aluminium hydroxide potentiates a protective Th1 biased immune response against polio virus that allows for dose sparing in mice and rats. Andreasen LV; Hansen LB; Andersen P; Agger EM; Dietrich J Vaccine; 2015 Apr; 33(15):1873-9. PubMed ID: 25698487 [TBL] [Abstract][Full Text] [Related]
20. [Aluminium adjuvant exposure through vaccines in France in 2018]. Angrand L; Elnar AA; Authier FJ; Gherardi RK; Crépeaux G Ann Pharm Fr; 2020 Mar; 78(2):111-128. PubMed ID: 32081303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]